By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MediGene AG 

Lochhamer Str. 11

Martinsried    82152   Germany
Phone: 49-89-85 65 29-00 Fax: 49-89-85 65 29-20



Company News
MediGene AG (MDGEF.PK) Expands TCR Platform Technology With US Patent For Method For Identification Of CD4+ T Cell Antigens 7/25/2016 9:21:30 AM
MediGene AG (MDGEF.PK) Joins Max Delbruck Center And Charité For First Clinical TCR Study In Germany 6/29/2016 11:45:31 AM
MediGene AG (MDGEF.PK): Notice To The Holders Of The Zero Coupon Convertible Bond 2014/2016 (The "Notes") Of Medigene AG (The "Issuer") 6/10/2016 11:06:43 AM
MediGene AG (MDGEF.PK) Commissions EUFETS For Cell Production Process For First Own TCR Studies 5/18/2016 9:08:47 AM
MediGene AG (MDGEF.PK) Reports Results Of First Quarter 2016 5/12/2016 9:43:27 AM
Clinical Data Of MediGene AG (MDGEF.PK)'s Dendritic Cell (DC) Vaccines In AML Presented At CIMT Conference 5/11/2016 9:00:57 AM
MediGene AG (MDGEF.PK) Participates At Three National And International Conferences 4/21/2016 9:13:12 AM
Clinical Data From IIT Using MediGene AG (MDGEF.PK)'s Dendritic Cell (DC) Vaccines In Prostate Cancer Presented At AACR Conference 4/19/2016 10:18:46 AM
MediGene AG (MDGEF.PK) Sells Partial Stake In Immunocore 4/4/2016 11:44:27 AM
MediGene AG (MDGEF.PK) Announces Start Of Phase II Trial With DC Vaccines And Upcoming Milestone Payment 4/1/2016 9:37:44 AM